source
- Murder suspect plans psychiatric defense in killing of UnitedHealthcare CEOLuigi Mangione has told the court he will rely on a psychiatric defense, arguing that he was suffering from extreme emotional disturbance when he shot UnitedHealthcare chief Brian Thompson. If a j…
- Neumora ends development of navacaprant after failed Phase 3 depression trials; EnGene cuts half its workforceNeumora Therapeutics announced it will discontinue its kappa opioid receptor antagonist navacaprant after the drug missed its primary endpoints in two Phase 3 studies for major depressive disorder.…